Washington, D.C., FDA & Life Science partner Eva Temkin will speak at the DIA Biosimilars Conference on Oct. 5. Eva will participate in a panel discussion titled “How Different Is Too Different? Differentiation Opportunities and Challenges for Biosimilars.” This panel will focus on US and EU regulatory frameworks for biosimilars and opportunities for differentiation.